Allergy Therapeutics plc has been mentioned in a Form 8.5 (EPT/RI) disclosure by Panmure Gordon (UK) Limited. The form provides key information about the dealings of the exempt principal trader with Allergy Therapeutics plc. The form states that on November 6, 2023, Panmure Gordon (UK) Limited made purchases and sales of Allergy Therapeutics plc's 0.1p ordinary shares. The form also mentions that there were no cash-settled derivative transactions or stock-settled derivative transactions involving options. Additionally, there were no other dealings, such as subscribing for new securities. The form concludes with contact information for Freddie Wooding at Panmure Gordon (UK) Limited.